The First US Study to Assess the Feasibility and Safety of Endocardial Delivery of Allogenic Mesenchymal Precursor Cells in Patient With Heart Failure: Three-Month Interim Analysis
Appointed International Principal Investigator
Appointed International Principal Investigator for clinical trial in patients with severe coronary heart disease.